Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6172)
All Articles published online
|
Publishing Process of This Article
|
Dec 26, 2020 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kokkorakis N, Gaitanou M. Minibrain-related kinase/dual-specificity tyrosine-regulated kinase 1B implication in stem/cancer stem cells biology. World J Stem Cells 2020; 12(12): 1553-1575 [PMID: 33505600 DOI: 10.4252/wjsc.v12.i12.1553] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v12/i12/1553.htm |
| Number | Citing Articles |
| 1 |
Lise Folon, Morgane Baron, Victoria Scherrer, Bénédicte Toussaint, Emmanuel Vaillant, Hélène Loiselle, Aurélie Dechaume, Frédérique De Pooter, Raphaël Boutry, Mathilde Boissel, Aboubacar Diallo, Lijiao Ning, Beverley Balkau, Guillaume Charpentier, Sylvia Franc, Michel Marre, Mehdi Derhourhi, Philippe Froguel, Amélie Bonnefond. Pathogenic, Total Loss-of-Function DYRK1B Variants Cause Monogenic Obesity Associated With Type 2 Diabetes. Diabetes Care 2024; 47(3): 444 doi: 10.2337/dc23-1851
|
| 2 |
Nikolaos Kokkorakis, Marios Zouridakis, Maria Gaitanou. Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy. Pharmaceutics 2024; 16(4): 528 doi: 10.3390/pharmaceutics16040528
|
| 3 |
N. Kokkorakis, K. Douka, A. Nalmpanti, P. K. Politis, L. Zagoraiou, R. Matsas, M. Gaitanou. Mirk/Dyrk1B controls ventral spinal cord development via Shh pathway. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-023-05097-9
|
| 4 |
Soraya Sester, Gerrit Wilms, Joana Ahlburg, Aaron Babendreyer, Walter Becker. Elevated expression levels of the protein kinase DYRK1B induce mesenchymal features in A549 lung cancer cells. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-13057-0
|
| 5 |
Mattias F. Lindberg, Laurent Meijer. Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview. International Journal of Molecular Sciences 2021; 22(11): 6047 doi: 10.3390/ijms22116047
|
| 6 |
Thamrong Wongchang, Panwadee Pluangnooch, Suradej Hongeng, Adisak Wongkajornsilp, Dean Thumkeo, Kitipong Soontrapa. Inhibition of DYRK1B suppresses inflammation in allergic contact dermatitis model and Th1/Th17 immune response. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-34211-x
|
| 7 |
Joana G. P. Jacinto, Marilena Bolcato, Irene M. Häfliger, Anna Oevermann, Arcangelo Gentile, Cord Drögemüller. DYRK1B haploinsufficiency in a Holstein cattle with epilepsy. Animal Genetics 2023; 54(5): 623 doi: 10.1111/age.13348
|
| 8 |
Kaibo Guo, Yuqian Feng, Xueer Zheng, Leitao Sun, Harpreet S. Wasan, Shanming Ruan, Minhe Shen. Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.644134
|
| 9 |
Azam Armanmehr, Hossein Jafari Khamirani, Sina Zoghi, Mehdi Dianatpour. Analysis of DYRK1B, PPARG, and CEBPB Expression Patterns in Adipose-Derived Stem Cells from Patients Carrying DYRK1B R102C and Healthy Individuals During Adipogenesis. Metabolic Syndrome and Related Disorders 2022; 20(10): 576 doi: 10.1089/met.2021.0140
|